Height outcome of the recombinant human growth hormone treatment in Turner syndrome: a meta-analysis
Authors:
Open Access
- 1 April 2018
- journal article
- research article
- Published by Bioscientifica in Endocrine Connections
- Vol. 7 (4) , 573-583
Abstract
Objective: This study sought to determine the effect of the recombinant human growth hormone (rhGH) treatment of Turner syndrome (TS) on height outcome. Methods: We searched in MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews. A literature search identified 640 records. After screening and full-text assessment, 11 records were included in the systematic review. Methodological quality was assessed using the Cochrane Risk of Bias tool. RevMan 5.3 software was used for meta-analysis. We also assessed the quality of evidence with the GRADE system. Results: Compared with controls, rhGH therapy led to increased final height (MD = 7.22 cm, 95% CI 5.27–9.18, P < 0.001, I2 = 4%; P = 0.18), height standard deviation (HtSDS) (SMD = 1.22, 95% CI 0.88–1.56, P < 0.001, I2 = 49%; P = 0.14) and height velocity (HV) (MD 2.68 cm/year; 95% CI 2.34, 3.02; P < 0.001, I2 = 0%; P = 0.72). There was a small increase in bone age (SMD 0.32 years; 95% CI 0.1, 0.54; P = 0.004, I2 = 73%; P = 0.02) after rhGH therapy for 12 months. What is more, the rhGH/oxandrolone combination therapy suggested greater final height (MD 2.46 cm; 95% CI 0.73, 4.18; P = 0.005, I2 = 32%; P = 0.22), increase and faster HV (SMD 1.67 cm/year; 95% CI 1.03, 2.31; P < 0.03, I2 = 80%; P < 0.001), with no significant increase in HtSDS and bone maturation compared with rhGH therapy alone. Conclusions: For TS patients, rhGH alone or with concomitant use of oxandrolone treatment had advantages on final height.Keywords
This publication has 39 references indexed in Scilit:
- GRADE guidelines 6. Rating the quality of evidence—imprecisionJournal of Clinical Epidemiology, 2011
- GRADE guidelines: 7. Rating the quality of evidence—inconsistencyJournal of Clinical Epidemiology, 2011
- GRADE guidelines: 9. Rating up the quality of evidenceJournal of Clinical Epidemiology, 2011
- Growth Hormone plus Childhood Low-Dose Estrogen in Turner's SyndromeNew England Journal of Medicine, 2011
- Favorable Final Height Outcome in Girls with Ullrich-Turner Syndrome Treated with Low-Dose Growth Hormone Together with Oxandrolone Despite Starting Treatment After 10 Years of AgeJournal of Pediatric Endocrinology and Metabolism, 2002
- Growth hormone therapy of Turner's syndrome: Beneficial effect on adult heightThe Journal of Pediatrics, 1998
- Variable effect of growth hormone on growth and final adult height in Scottish patients with Turner's syndromeActa Paediatrica, 1997
- Study of final height in Turner's syndrome: ethnic and genetic influencesActa Paediatrica, 1994
- Chromosome abnormalities found among 34910 newborn children: results from a 13-year incidence study in rhus, DenmarkHuman Genetics, 1991
- Adult height in Turner syndrome with and without androgen therapyThe Journal of Pediatrics, 1984